Welcome to our dedicated page for Align Technology news (Ticker: ALGN), a resource for investors and traders seeking the latest updates and insights on Align Technology stock.
Align Technology reports developments in digital orthodontics and restorative dentistry through its Invisalign System of clear aligners, iTero intraoral scanners, exocad CAD/CAM software and the Align Digital Platform. Company news commonly covers product and workflow updates for clear-aligner treatment planning, intraoral scanning, 3D visualization and digitally connected dental practices.
Recurring updates also include quarterly and annual operating results, clear-aligner shipment and channel trends, regional demand, foreign-exchange effects, stock repurchase activity, financial-conference participation and governance or shareholder-voting matters. Other announcements describe clinical education, professional collaborations and access-to-care initiatives involving orthodontists, general practitioner dentists and dental research organizations.
Align Technology (Nasdaq: ALGN) awarded $300,000 in research grants to twelve universities worldwide under its fifteenth Annual Research Award Program. Projects span the Americas, Europe, and Asia Pacific and focus on topics such as apical root resorption, aligner-based expansion, white spot lesions, retention stability, and enamel characteristics during aligner treatment.
According to Align Technology, applications were blind-reviewed by an independent academic committee before final selection. The company highlights this program as part of its support for scientific research in orthodontics and dentistry.
Align Technology (Nasdaq: ALGN) plans a new multi-million dollar manufacturing facility in Hyderabad, India, expected to start operations in 2027. The company plans to invest approximately $200 million in capital and operational expenses over several years and create 300+ direct jobs.
The Hyderabad site will be Align’s first manufacturing facility in India and its fourth globally, aimed at supporting high-growth markets like India and the Asia-Pacific region, improving supply chain resilience, and enhancing localized service for Invisalign-trained doctors. The facility is expected to be margin accretive in its first year of operation and falls within Align’s 2026 capital equipment guidance.
Align Technology (Nasdaq: ALGN) hosted the 2026 Invisalign EMEA Ortho Summit in Barcelona, gathering about 400 orthodontists from Europe, the Middle East, and Africa. The three-day event showcased integrated digital orthodontic solutions, including Invisalign Specifix Attachment System, integrated buttons, enhanced Palatal Expander features, custom trimlines, and 3D Soft Tissue Animation.
Align Technology (Nasdaq: ALGN) will present at several upcoming investor conferences, including Stifel, William Blair, Jefferies, and Goldman Sachs events between May 28 and June 8, 2026.
All presentations will be webcast live and archived for about one month on Align's investor relations website.
Align Technology (Nasdaq: ALGN) announced a $200.0 million open‑market repurchase of common stock under its existing $1.0 billion buyback program approved April 2025. Repurchases will use a Rule 10b5-1 trading plan, be funded with cash on hand, and are expected to complete by October 2026.
As of March 31, 2026, Align reported 71.6 million shares outstanding and $1,059.8 million in cash and cash equivalents, including $206.6 million held domestically allocated to support the repurchases.
Align Technology (Nasdaq: ALGN) previewed mid-2026 product innovations at AAO 2026, showcasing Invisalign Specifix™ 3D printed attachments, Invisalign integrated buttons, and an Invisalign Palatal Expander with integrated hooks, plus iTero Lumina™ scanner and ClinCheck® platform enhancements to extend digital treatment planning, 3D printing, and connected workflows.
The release highlights independent clinical validation showing the Invisalign Palatal Expander produced bone and bite changes comparable to a traditional Hyrax expander and details limited-market custom trimline options.
Align Technology (NASDAQ: ALGN) reported Q1'26 revenue of $1,040.1M, up 6.2% year-over-year and down 0.7% sequentially. Record Clear Aligner shipments reached 685,650 cases, up 6.7% year-over-year. GAAP diluted EPS was $1.57; non-GAAP diluted EPS was $2.58. The company completed a $200M repurchase plan and expects to repurchase an additional $200M beginning on or about May 1, 2026. Management reaffirmed full-year 2026 revenue growth guidance of +3% to +4% and reiterated targets for operating margins, capex, and volume growth.
Align Technology (Nasdaq: ALGN) was named a Top 100 Global Innovator in the LexisNexis Innovation Momentum 2026 report for the fifth consecutive year, earning a “Five‑Year Top 100 Global Innovator” distinction.
Align cites a global portfolio of more than 3,000 active patents and patent applications, ~295.6 thousand doctor customers, and innovation across AI treatment planning, direct 3D printing, digital diagnostics, and ortho‑restorative design.
Align Technology (Nasdaq: ALGN) will report first quarter 2026 results on April 29, 2026 after market close. Financial results will be released at 4:00 p.m. ET and the company will host a conference call at 4:30 p.m. ET with a live audio webcast.
The webcast will be available on the Investor Relations site, participants may pre-register, and an archived audio webcast will be posted two hours after the call and remain available for one month. Align cites ~295.6k doctor customers, a 600 million consumer market opportunity, and ~22.1 million patients treated over 29 years.
Align Technology (Nasdaq: ALGN) will present at two financial conferences in Miami on March 10–11, 2026. Presentations are scheduled at the Leerink Partners Global Healthcare Conference on March 10 at 9:20–9:50 a.m. ET and at the Barclays 28th Annual Global Healthcare Conference on March 11 at 8:30–8:55 a.m. ET.
Speakers include John Morici, EVP Global Finance and CFO, and Madelyn Valente, Director Corporate Communications Investor Relations. Both presentations will be webcast live via the company investor relations website, with archived replays available for about one month.